A Chiesi Farmaceutici SpA patent details cyclohexane acid derivatives acting as lysophosphatidic acid receptor 1 (LPAR1; EDG2) antagonists and thus reported to be useful for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback